Ophthalmological bioerodible drug dispensing formulation

Details Ophthalmological bioerodible drug dispensing formulation Ophthalmological bioerodible drug dispensing formulation

1975-07-02

1977-01-04

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

128260, 424 16, 424 19, 424 20, 424 32, 424 33, A61K 914, A61K 922, A61K 932

Patent

active

040013880

ABSTRACT:
An ophthalmological bioerodible dosage form for ophthalmic drugs is disclosed. The dosage form comprises particles 10 to 300 microns made of drug dispersed within a drug release rate controlling material which bioerodes in the environment of the eye.

REFERENCES:
patent: 2671750 (1954-03-01), Macek
patent: 2828319 (1958-03-01), Magerlein et al.
patent: 2861920 (1958-11-01), Dale et al.
patent: 2897120 (1959-07-01), Cronin et al.
patent: 3062712 (1962-11-01), Dale et al.
patent: 3755558 (1973-08-01), Scribner
patent: 3773919 (1973-11-01), Boswell et al.
patent: 3826258 (1974-07-01), Abraham
patent: 3867519 (1975-02-01), Michaels
patent: 3887699 (1975-06-01), Yolles
patent: 3914402 (1975-10-01), Shell
Speiser Chem. Abst., 67, No. 14813n (1967) "Ophthalmic Dispersions and Preparations", Abst. of Farmaco., Ed. Pract., 22(4):181-209 (1967).(FR).

Affiliated with

Also associated with

Rating

Ophthalmological bioerodible drug dispensing formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmological bioerodible drug dispensing formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmological bioerodible drug dispensing formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-254766